Evidence map›Paper›PMID 32149225›Full record

ArticleACS omega2020

Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1.

Jie Yang, Vladimir O Talibov, Stefan Peintner, Claire Rhee, Vasanthanathan Poongavanam, Matthis Geitmann, Matteo Rossi Sebastiano, Bernd Simon, Janosch Hennig, Doreen Dobritzsch and 2 more

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jie YangDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Vladimir O TalibovDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Stefan PeintnerDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Claire RheeDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Vasanthanathan PoongavanamDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Matthis GeitmannBeactica AB, Uppsala Business Park, Virdings allé 2, SE-75450 Uppsala, Sweden.
Matteo Rossi SebastianoDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Bernd SimonStructural and Computational Biology Unit, EMBL Heidelberg, Meyerhofstraße 1, 69117 Heidelberg, Germany.
Janosch HennigStructural and Computational Biology Unit, EMBL Heidelberg, Meyerhofstraße 1, 69117 Heidelberg, Germany.
Doreen DobritzschDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
U Helena DanielsonDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Jan KihlbergDepartment of Chemistry-BMC, Uppsala University, Box 576, SE-75123 Uppsala, Sweden.
Uppsala University · SEBeactica (Sweden) · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lysine-specific demethylase 1 (LSD1) is an epigenetic enzyme which regulates the methylation of Lys4 of histone 3 (H3) and is overexpressed in certain cancers. We used structures of H3 substrate analogues bound to LSD1 to design macrocyclic peptide inhibitors of LSD1. A linear, Lys4 to Met-substituted, 11-mer (

Identifiers

PMID32149225
PMCPMC7057333
OpenAlexW3005728751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.